Related Experiment Video

Updated: Sep 23, 2026

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Regression of left ventricular hypertrophy is a key goal of hypertension management

Rubin Zhang1, Judy Crump, Efrain Reisin

  • 1Louisiana State University Health Sciences Center, Department of Medicine, Section of Nephrology, 1542 Tulane Avenue, Box T3M-2/A319, New Orleans, LA 70112-2822, USA.

Current Hypertension Reports
|July 8, 2003
PubMed

Insights

Left ventricular hypertrophy (LVH) in hypertensive patients increases cardiovascular risk and mortality. Effective antihypertensive therapy, particularly ACE inhibitors and ARBs, can reverse LVH, reducing adverse outcomes.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiovascular Pathology

Background:

  • Left ventricular hypertrophy (LVH) in hypertension is a significant risk factor for cardiovascular events and mortality.
  • The development of LVH is multifactorial, involving hemodynamic stress and various trophic humoral factors.
  • Effective antihypertensive treatment can prevent and reverse LVH, leading to improved patient outcomes.

Purpose of the Study:

  • To review the role of hypertension in left ventricular hypertrophy.
  • To discuss the complex pathogenesis of LVH.
  • To evaluate the efficacy of current and novel therapeutic strategies for LVH.

Main Methods:

  • Literature review of studies on hypertension, LVH, and cardiovascular outcomes.
  • Analysis of the mechanisms contributing to LVH development and progression.
  • Evaluation of the impact of different antihypertensive drug classes on LVH regression.

Main Results:

  • LVH in hypertensive patients is linked to increased cardiovascular morbidity and mortality.
  • Angiotensin II, aldosterone, endothelin, leptin, and catecholamines are implicated in LVH pathogenesis.
  • Angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors demonstrate significant efficacy in reversing LVH.

Conclusions:

  • Regression of LVH through effective antihypertensive therapy is crucial for reducing cardiovascular risk.
  • ARBs and ACE inhibitors are highly effective in managing LVH.
  • Emerging therapies targeting LVH pathogenesis, such as antifibrotic drugs and endothelin receptor antagonists, offer promising new treatment avenues.

More Related Videos

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...